PRESS RELEASES PRESS RELEASESJuly 6 - 2021Epify progresses colorectal cancer program and files first patent application on a broad range of applicationsREAD MOREMarch 30 - 2021Epify signs agreement with Maastricht University to validate colorectal cancer biomarkers for early detectionREAD MORENovember 7 - 2019Epify Strengthens Management Team by Appointing Leander Van Neste as Chief Scientific OfficerREAD MORE September 25 - 2019Epify has been featured in a Genomeweb article"Dutch Startup Epify Raises €500,000 in Seed Funding". READ MORE September 25 - 2019Epify BV Raises 500,000 Euros in Seed Round to Develop Epigenetic Biomarkers for Cancer Diagnosis and Personalized TreatmentREAD MORE
